Blueshift Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Blueshift Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,206	Closed	-$387K	–	1279
2021 Q1	$387K	Buy	+16,206	New	+$301K	0.04%	565

Blueshift Asset Management's GNMK Position: Q2 2021 in Review

Blueshift Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 16,206 shares — an estimated $387K sold.

Blueshift Asset Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $387K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Blueshift Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Blueshift Asset Management sold 16,206 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $387K.
Blueshift Asset Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Blueshift Asset Management's GenMark Diagnostics, Inc position peaked at $387K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.